Elevare Consulting Group的动态

?? From the PEERLESS RCT Trial data, Dr Stefan Stortecky highlights that the primary endpoint was met, with a significant win ratio of 5.01 favouring large-bore mechanical thrombectomy versus catheter-directed thrombolysis in the treatment of intermediate risk pulmonary embolism. ?? Discover how these findings fit into the latest developments in pulmonary embolism (PE) management in this insightful video series ?? https://ow.ly/cW8L50Uu0KY This programme is supported by an unrestricted educational grant from Inari Medical. #PulmonaryEmbolism #InterventionalCardiology #PEManagement

?? Prof Thomas Cuisset reviews current pulmonary embolism treatment guidelines and discusses how emerging clinical trial evidence will reshape these in the coming years. ?? Learn strategies to enhance pulmonary embolism management in this series ?? https://ow.ly/i4WG50UAgEC This programme is supported by an unrestricted educational grant from Inari Medical. #PulmonaryEmbolism #InterventionalCardiology #PEManagement

?? Prof Thomas Cuisset reviews current pulmonary embolism treatment guidelines and discusses how emerging clinical trial evidence will reshape these in the coming years. ?? Learn strategies to enhance pulmonary embolism management in this series ?? https://ow.ly/i4WG50UAgEC This programme is supported by an unrestricted educational grant from Inari Medical. #PulmonaryEmbolism #InterventionalCardiology #PEManagement

Just hours ago, a paper detailing the two-year follow-up results of our Phase 1 clinical trial featuring CYP-001, our innovative Cymerus? off-the-shelf iPSC-derived MSC product, was published in the prestigious Nature Medicine journal. This is the second paper published in Nature Medicine regarding this trial which reports survival rate compares very favourably to previously reported outcomes in SR-aGvHD - 60% vs. historical prognosis of below 20% two-year overall survival rate. “The publication of a second paper on this trial in such a high-impact journal is a testament to the importance of this project to the wider field of cellular therapy,” John Rasko AO, the international coordinating Principal Investigator for the trial. Read the full announcement here: https://bit.ly/3IhTz71 #stemcells #innovation #aGvHD #NatureMedicine #newsalert

Here we go.... AGAIN!!! ?? **Exciting News!** ?? Thrilled to share the publication of our latest research paper "Systematic Review of Platelet-Rich Plasma in Medical and Surgical Specialties" in the Journal of Clinical Medicine! Our team's innovative system evaluates the quality of clinical trials, enhancing PRP research integrity. This scoring system assesses critical criteria like platelet count, centrifugation protocol, growth factor reporting, and aseptic techniques. Higher scores reflect better quality standards. Read the full paper here: ?? https://lnkd.in/eve-C-ct #ClinicalResearch #HealthcareInnovation #QualityAssessment #ClinicalTrials #ResearchExcellence Feel free to check it out and share your thoughts!

?? Pushing Boundaries in Advanced Vascular Diagnostics at Karolinska Institute: The Game-Changing Potential of TcPO2! As part of the Avancerad fysiologisk k?rldiagnostik program at Karolinska Institute, I’ve gone beyond the traditional duplex and imaging techniques in cardiovascular diagnostics to explore the untapped potential of transcutaneous oxygen pressure (TcPO2)—and what I’ve uncovered is nothing short of inspiring. TcPO2 doesn’t just help us predict wound healing or guide interventions to prevent amputations in diabetes; it opens up a whole new frontier for understanding how vascular health impacts could lead complex neurological diseases, but that really let me think! Imagine: what if conditions like Alzheimer’s, multiple sclerosis, and other neurodegenerative diseases could be evaluated based on their vascular components? With TcPO2’s precise insight into local oxygenation, we could detect subtle vascular deficiencies that contribute to neurodegeneration, possibly even tailoring treatments like hyperbaric therapy for more effective outcomes. ???? This tool is redefining diagnostics—not just for cardiovascular health but for a more integrated view of the body’s vascular and neurological systems. I’m thrilled to be at the cutting edge of this field, where innovative techniques like TcPO2 are transforming our approach to diagnosis, treatment, and preventive care across multiple domains of medicine, and I hope that my idea could turn to investigation ???? I wanted to share the link provided by Prof. Stefan Rosfors?about current use of TcPO2 to know that amazing technique better!

What are the barriers to #ESCGuidelines implementation in #cardiovascular medicine at a local, national and international level? Suleman Aktaa MD PhD opens our coverage of the #ESCardioCRT on this important topic. ?? Stay tuned! #CVD #cardiovasculardisease

What were the main scientific highlights and key learnings from #EuroPCR 2024, and what should you know about impact on practice? In this short session replay, Davide Capodanno summarises his key takeaways from this year's Course ? https://lnkd.in/d5XsMnQW (open access). Nieves Gonzalo Nicolas Dumonteil Thomas Cuisset #interventionalcardiology #clinicaltrials #latebreakingscience #trialupdates

Systematic reviews: The ultimate tool for evidence-based medicine. Here’s why they matter! "Systematic reviews and meta-analyses are the backbone of modern medicine. ? Systematic Reviews: Summarize all available evidence on a topic. ? Meta-Analyses: Combine data from multiple studies for stronger conclusions. ?? Trivia: The first systematic review in medicine was conducted in the 1700s to study scurvy treatments—an early win for evidence-based research! ?? Thinking of doing a systematic review? DM me—I’ll guide you step by step! #SystematicReview #MetaAnalysis #EvidenceBasedMedicine #DoctorsWhoResearch #SPSSHelp #MedicalResearch"

Join us for the next Advanced Topics in Pain Medicine lecture, where we discuss "Cervical TFESIs: Underutilized or Best Avoided?". This procedure is highly debated and rarely taught in fellowships. Whatever your stance, understanding the evidence is essential for informed practice. https://bit.ly/3CVUNFr